Glaxo's herpes vaccine fails in trial, US NIH says
September 30, 2010 at 09:21 AM EDT
WASHINGTON, Sept 30 (Reuters) - A trial of GlaxoSmithKline Plc's herpes vaccine failed to protect women against the virus, the U.S. National Institutes of Health said on Thursday.
